Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $144 at Wedbush, Following Earnings
Tweet
Share
E-mail
Get Alerts BHVN Hot Sheet
Price: $14.64 -1.41%
Rating Summary:
17 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
17 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Wedbush analyst Laura Chico lowered the price target on Biohaven Pharmaceutical Holding (NYSE: BHVN) to $144.00 (from $152.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Biohaven Pharma (BHVN) PT Raised to $23 at RBC Capital
- Zedcor Inc (ZDC:CN) PT Raised to Cdn$7.75 at Desjardins
- Honasa Consumer Ltd (HONASA:IN) PT Raised to INR720 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
